Cargando…
Anticoagulants and Immunosuppressants in COVID-19: Bullets to Defeat MicroCLOTS
Autores principales: | Turi, S, Nardelli, P, Landoni, G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559961/ https://www.ncbi.nlm.nih.gov/pubmed/32687078 http://dx.doi.org/10.4103/aca.ACA_126_20 |
Ejemplares similares
-
MicroCLOTS pathophysiology in coronavirus disease 2019
por: Renzi, Samuele, et al.
Publicado: (2023) -
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis
por: Ciceri, Fabio, et al.
Publicado: (2023) -
Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): a new variant of thrombotic microangiopathy?
por: Bobrova, Larisa, et al.
Publicado: (2023) -
Microclot array elastometry for integrated measurement of thrombus formation and clot biomechanics under fluid shear
por: Chen, Zhaowei, et al.
Publicado: (2019) -
The scientific approach to defeating Covid-19 disease
por: Muula, Adamson S
Publicado: (2020)